Cointime

GC

investment firm

About

GC is a long-time leader in South Korean public health and is a world-class stakeholder of the biopharmaceutical industry.

Highlights

Investments
1
Lead Investments
1

Details

Operating Status
Active

GC, through its affiliates, provides total healthcare solutions that address the evolving needs of human health. GC was founded in 1967 and is headquartered in Yongin, South Korea. The company is the parent company of GC Pharma (Green Cross Corporation) (KRX: 006280), the largest protein therapeutics manufacturer in Asia.

Investments

Number of Investments
Number of Lead Investments
1
1
GC has made 1 investments. Their most recent investment was on Sep 18, 2018, when Feldan Therapeutics raised $13.80M.
Date Company Name
Round Money Raised Industry Lead Investor
Sep 18, 2018 Feldan Therapeutics
Series A $13.80M Biotechnology Yes
Cointime
Content
Company